Oncotarget | Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001
“Taken together, these findings provide a strong rationale for potently and selectively targeting of CD74 in patients with B-NHL .” ...
“Taken together, these findings provide a strong rationale for potently and selectively targeting of CD74 in patients with B-NHL .” ...
Singapore’s drug discovery efforts reached a new milestone as EBC-129, the first made-in-Singapore antibody-drug conjugate, was cleared by the US ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.